Search Results - "Meerpohl, H.G."

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
  2. 2
  3. 3

    Extended phase II study of paclitaxel as a 3-h infusion in patients with ovarian cancer previously treated with platinum by du Bois, A., Lück, H.J., Buser, K., Meerpohl, H.G., Sessa, C., Klaassen, U., Meden, H., Bochtler, H., Diergarten, K.

    Published in European journal of cancer (1990) (01-03-1997)
    “…An extended phase II study was performed to evaluate single-agent paclitaxel as salvage chemotherapy for ovarian cancer. The aim of this study was to evaluate…”
    Get full text
    Journal Article
  4. 4

    Randomized Study Comparing Carboplatin/Cyclophosphamide and Cisplatin/Cyclophosphamide as First-Line Treatment in Patients with Stage III/IV Epithelial Ovarian Cancer and Small Volume Disease by Meerpohl, H.G., Sauerbrei, W., Kühnle, H., Schumacher, M., Pfleiderer, A.

    Published in Gynecologic oncology (01-07-1997)
    “…Several randomized studies in patients with advanced ovarian cancer have dealt with the comparison of cisplatin and carboplatin when given as either a single…”
    Get full text
    Journal Article
  5. 5

    Course, patterns, and risk-factors for chemotherapy-induced emesis in cisplatin-pretreated patients: a study with ondansetron by du Bois, A, Meerpohl, H G, Vach, W, Kommoss, F G, Fenzl, E, Pfleiderer, A

    Published in European journal of cancer (1990) (1992)
    “…Vomiting and nausea are the most distressing side-effects of cancer chemotherapy. With standard antiemetic regimens (e.g. metoclopramide based combinations)…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Clinical phase I study with one-hour paclitaxel infusion by Mross, K., Hauns, B., H˚ring, B., Bauknecht, T., Meerpohl, H. G., Unger, C., Maier-Lenz, H.

    Published in Annals of oncology (01-05-1998)
    “…Background Paclitaxel (PAC) is one of the major anti-cancer drugs, effective in different tumors. Studies with 24-hour infusion with 135 mg/m2 and a three-hour…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Positron emission tomography helps to diagnose tumor emboli and residual disease in choriocarcinoma by HEBART, H, ERLEY, C, KASKAS, B, MAYER, R, KÖNIG, M, EINSELE, H, BOKEMEYER, C, MEERPOHL, H. G, FEINE, U, KANZ, L

    Published in Annals of oncology (01-04-1996)
    “…Positron emission tomography (PET) has been shown capable of identifying malignant tissues. WB-PET imaging in two women with metastatic choriocarcinoma is…”
    Get full text
    Journal Article
  10. 10

    Pathophysiology, severity, pattern, and risk factors for carboplatin-induced emesis by du Bois, A, Vach, W, Kiechle, M, Cramer-Giraud, U, Meerpohl, H G

    Published in Oncology (01-01-1996)
    “…Carboplatin has proven efficacy in the treatment of ovarian cancer and has been proven to be less toxic compared to the parent compound cisplatin…”
    Get more information
    Journal Article
  11. 11

    Paclitaxel-Induced “Recall” Soft Tissue Ulcerations Occurring at the Site of Previous Subcutaneous Administration of Paclitaxel in Low Doses by du Bois, A., Kommoss, F.G.M., Pfisterer, J., Lück, H.J., Meerpohl, H.G.

    Published in Gynecologic oncology (01-01-1996)
    “…The presented case reports a rare complication of paclitaxel misuse: recall soft tissue injury at the site of previous subcutaneous paclitaxel administration…”
    Get full text
    Journal Article Conference Proceeding
  12. 12

    Role of prostaglandins on the regulation of macrophage proliferation and cytotoxic functions by Meerpohl, H G, Bauknecht, T

    Published in Prostaglandins (01-05-1986)
    “…The data presented show different effects of prostaglandins on proliferation and cytotoxic effector functions of murine bone-marrow derived mononuclear cells…”
    Get more information
    Journal Article
  13. 13

    Formation of prostaglandins by ovarian carcinomas by Bauknecht, T, Siegel, A, Meerpohl, H G, Zahradnik, H P

    Published in Prostaglandins (01-05-1985)
    “…Tissue contents of prostaglandins (PG) PGE2, PGE2a and 6-keto-PGF1a (degradation product of PGI2) were determined in specimens of advanced human ovarian cancer…”
    Get more information
    Journal Article
  14. 14

    Chemotherapy for stage III-IV ovarian cancer: the CAP-regimen in previously untreated patients by Meerpohl, H G, Pfleiderer, A, Kleine, W, Teufel, G

    Published in Onkologie (01-01-1982)
    “…Twenty-nine patients with advanced previously untreated epithelial ovarian cancer (FIGO stage III + IV) received induction chemotherapy with CAP…”
    Get more information
    Journal Article